▶ 調査レポート

ピークフローメーターのグローバル市場(2022年-2031年):デジタルピークフローメーター、メカニカルピークフローメーター

• 英文タイトル:Peak Flow Meter Market (Product: Digital Peak Flow Meter and Mechanical Peak Flow Meter; Indication: Chronic Obstructive Pulmonary Disease, Asthma, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。ピークフローメーターのグローバル市場(2022年-2031年):デジタルピークフローメーター、メカニカルピークフローメーター / Peak Flow Meter Market (Product: Digital Peak Flow Meter and Mechanical Peak Flow Meter; Indication: Chronic Obstructive Pulmonary Disease, Asthma, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2304D111資料のイメージです。• レポートコード:MRC2304D111
• 出版社/出版日:Transparency Market Research / 2023年1月17日
• レポート形態:英文、PDF、164ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥869,250 (USD5,795)▷ お問い合わせ
  Multi User¥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License¥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の当調査レポートでは、ピークフローメーターの世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定&調査手法、エグゼクティブサマリー、市場概要、キーインサイト、市場分析&予測、製品別(デジタルピークフローメーター、メカニカルピークフローメーター)分析、疾患別(慢性閉塞性肺疾患、喘息、その他)分析、エンドユーザー別(病院&クリニック、在宅医療、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを収録しています。また、DeVilbiss Healthcare LLC、Koninklijke Philips N.V.、Vitalograph Ltd.、ResMed, Inc.、Haag-Streit Group、Medline Industries, Inc.、nSpire Health, Inc.、Teleflex, Inc.、Vyaire Medical, Inc.、Omron Healthcare Co., Ltd.、Ambisea Technology、Contec Medical Systemsなどの企業情報を掲載しています。
・序論
・仮定&調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・市場分析&予測
・世界のピークフローメーター市場規模:製品別
- デジタルピークフローメーターの市場規模
- メカニカルピークフローメーターの市場規模
・世界のピークフローメーター市場規模:疾患別
- 慢性閉塞性肺疾患における市場規模
- 喘息における市場規模
- その他疾患における市場規模
・世界のピークフローメーター市場規模:エンドユーザー別
- 病院&クリニックにおける市場規模
- 在宅医療における市場規模
- その他エンドユーザーにおける市場規模
・世界のピークフローメーター市場規模:地域別
- 北米のピークフローメーター市場規模
- ヨーロッパのピークフローメーター市場規模
- アジア太平洋のピークフローメーター市場規模
- 中南米のアルミニウムスラグ市場規模
- 中東・アフリカのアルミニウムスラグ市場規模
・競争状況

Peak Flow Meter Market – Scope of Report
TMR’s report on the global peak flow meter market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global peak flow meter market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peak flow meter market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the peak flow meter market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peak flow meter market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global peak flow meter market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peak flow meter market.

The report delves into the competitive landscape of the global peak flow meter market. Key players operating in the global peak flow meter market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global peak flow meter market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market peak flow meter.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Peak Flow Meter Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Peak Flow Meter Market Analysis and Forecast, 2017–2031
    4.5. Porter’s Five Forces Analysis
5. Key Insights
    5.1. Insights on Prevalence and Incidence of Respiratory Disease
    5.2. Pricing Analysis
    5.3. Technological Advancement
    5.4. Key Industry Events
    5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long-term impact)
6. Global Peak Flow Meter Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product, 2017–2031
        6.3.1. Digital Peak Flow Meter
        6.3.2. Mechanical Peak Flow Meter
    6.4. Market Attractiveness Analysis, by Product
7. Global Peak Flow Meter Market Analysis and Forecast, by Indication
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Indication, 2017–2031
        7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
        7.3.2. Asthma
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by Indication
8. Global Peak Flow Meter Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals & Clinics
        8.3.2. Homecare Settings
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Peak Flow Meter Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Peak Flow Meter Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017–2031
        10.2.1. Digital Peak Flow Meter
        10.2.2. Mechanical Peak Flow Meter
    10.3. Market Value Forecast, by Indication, 2017–2031
        10.3.1. Chronic Obstructive Pulmonary Disease (COPD)
        10.3.2. Asthma
        10.3.3. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals & Clinics
        10.4.2. Homecare Settings
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Indication
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Peak Flow Meter Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017–2031
        11.2.1. Digital Peak Flow Meter
        11.2.2. Mechanical Peak Flow Meter
    11.3. Market Value Forecast, by Indication, 2017–2031
        11.3.1. Chronic Obstructive Pulmonary Disease (COPD)
        11.3.2. Asthma
        11.3.3. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals & Clinics
        11.4.2. Homecare Settings
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Indication
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Peak Flow Meter Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017–2031
        12.2.1. Digital Peak Flow Meter
        12.2.2. Mechanical Peak Flow Meter
    12.3. Market Value Forecast, by Indication, 2017–2031
        12.3.1. Chronic Obstructive Pulmonary Disease (COPD)
        12.3.2. Asthma
        12.3.3. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals & Clinics
        12.4.2. Homecare Settings
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Indication
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Peak Flow Meter Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017–2031
        13.2.1. Digital Peak Flow Meter
        13.2.2. Mechanical Peak Flow Meter
    13.3. Market Value Forecast, by Indication, 2017–2031
        13.3.1. Chronic Obstructive Pulmonary Disease (COPD)
        13.3.2. Asthma
        13.3.3. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals & Clinics
        13.4.2. Homecare Settings
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of LATAM
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Indication
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Peak Flow Meter Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017–2031
        14.2.1. Digital Peak Flow Meter
        14.2.2. Mechanical Peak Flow Meter
    14.3. Market Value Forecast, by Indication, 2017–2031
        14.3.1. Chronic Obstructive Pulmonary Disease (COPD)
        14.3.2. Asthma
        14.3.3. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals & Clinics
        14.4.2. Homecare Settings
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Indication
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competitive Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company (2021)
    15.3. Company Profiles
        15.3.1. DeVilbiss Healthcare LLC
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Koninklijke Philips N.V.
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Medline Industries, Inc.
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Omron Healthcare Co., Ltd.
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. ResMed, Inc.
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Teleflex, Inc.
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Vitalograph Ltd.
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. Vyaire Medical, Inc.
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Ambisea Technology
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview
        15.3.10. Contec Medical Systems
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Financial Overview
            15.3.10.5. Strategic Overview
        15.3.11. nSpire Health, Inc.
            15.3.11.1. Company Overview
            15.3.11.2. Product Portfolio
            15.3.11.3. SWOT Analysis
            15.3.11.4. Financial Overview
            15.3.11.5. Strategic Overview
        15.3.12. Haag-Streit Group
            15.3.12.1. Company Overview
            15.3.12.2. Product Portfolio
            15.3.12.3. SWOT Analysis
            15.3.12.4. Financial Overview
            15.3.12.5. Strategic Overview